- Home
- Innovation
Innovation
She’s a scientist with one of the world’s most important jobs: Creating a potential COVID-19 vaccine
Imagine being a researcher who is staring down not only a highly infectious virus, but one that’s caused the first global pandemic in more than 100 years. Meet Johnson & Johnson’s Hanneke Schuitemaker, Ph.D.
“I’m racing to screen thousands of molecules": These scientists are canvassing a vast library in search of a potential COVID-19 treatment
Johnson & Johnson has an expansive archive of existing drug compounds—and two researchers are leading the charge in combing through this molecular storehouse in pursuit of a possible breakthrough.
JLABS @ Washington, DC: The unique innovation hub that’s poised to help protect us from future pandemics
Scientists at the facility, opening in the nation’s capital this year, will be focused on advancing breakthrough ideas for safeguarding people around the world from pandemics like COVID-19, infectious diseases and other health threats.
Chairman and CEO Alex Gorsky profiled by the Financial Times about Johnson & Johnson’s work on a potential COVID-19 vaccine
The article explores what guided the decision, which is just the latest example of our Chairman and CEO’s people-first approach to leadership at our healthcare company.
“I’m a scientist working on a potential COVID-19 vaccine”: Meet a researcher who’s studying a promising candidate
Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus.
6 impactful ways Johnson & Johnson is helping in the fight against COVID-19
From work on an investigational vaccine candidate to a $50 million commitment in support of healthcare workers on the very front lines of the crisis around the world, learn how the company has taken action to help respond to the pandemic.
“I have never seen a moment so rich in collaboration, ingenuity and acts of bravery": Johnson & Johnson announces it has identified a lead COVID-19 vaccine candidate
Chairman & CEO Alex Gorsky shares that the company could have the first batches of a COVID-19 vaccine available for emergency-use authorization in early 2021—a substantially accelerated time frame in comparison to the typical vaccine development process.
What you need to know about how Johnson & Johnson’s supply chain is responding to the COVID-19 pandemic
The company’s Chief Global Supply Chain Officer shares the measures the company has taken to maintain its supply chain operations during the current novel coronavirus outbreak.
What it really feels like to have multiple sclerosis
The exact cause of the disease is unknown, but there’s a lot scientists do know about how it impacts nearly every part of the body. Scientists like Tatiana Scherz, M.D., who takes us on a guided journey of how the disease manifests—from your brain down to your toes.
Can an Apple Watch reduce the likelihood of suffering a stroke? The innovative study that’s tackling the problem of AFib
Cardiologist C. Michael Gibson is heading up a virtual research study that uses wearable technology and cutting-edge apps to help detect atrial fibrillation, one of the biggest risk factors for stroke. We dive into how the study will work.